To indicate the possibility of allergic airway inflammation by lactoferrin, following experiments might be needed in the future: oral administration without alum adjuvant, mice strain differences in the pathogenesis of human lactoferrin‐induced airway inflammation, and comparative study using recombinant lactoferrin instead of human lactoferrin. This evidence concerns the gene LTF and inflammation.